Skip Navigation
Skip to contents

ICDM 2020

Corporate symposia

Program at a glance Scientific Program Social Program Education Course

Plenary lectures Main sympsia Research group and committee session Special and award session Corporate symposia Video on demand session Oral presentations
Satellite symposium 1 Sponsored by BI-LLY 12:50~13:10 / Friday 18 September
Channel A
Chairman:Moon-Kyu Lee
David Z. Cherney
University of Toronto, Canada
 SS1 SGLT2 Inhibition: role in T2D and related complications
Satellite symposium 2 Sponsored by Handok 12:50~13:10 / Friday 18 September
Channel B
Chairman:Hyoung Woo Lee
Bo Kyung Koo
Seoul National University, Korea
 SS2 The multiple benefits of SGLT-2i: ideal option for Asian T2DM patients
Satellite symposium 3 Sponsored by Chongkundang 12:50~13:10 / Friday 18 September
Channel C
Chairman:Jae Myung Yu
Soo Lim
Seoul National University, Korea
 SS3 The beneficial effects of lobeglitazone combination therapy
Satellite symposium 4 Sponsored by MSD 12:50~13:10 / Friday 18 September
Channel D
Chairman:Kyung Wan Min
Eun Seok Kang
Yonsei University, Korea
 SS4 Strategic T2DM treatment in broad range of patients
Satellite symposium 5 Sponsored by Novonordisk 08:30~08:50 / Saturday 19 September
Channel A
Chairman:Ho Sang Shon
Young Min Cho
Seoul National University, Korea
 SS5 Clinical values of the new basal insulin & GLP-1 fixed ratio co-formulation
Satellite symposium 6 Sponsored by Takeda 08:30~08:50 / Saturday 19 September
Channel B
Chairman:Dong-Sun Kim
Dae Jung Kim
Ajou University, Korea
 SS6 The power of one pill, NesinaAct for T2DM patients
Satellite symposium 7 Sponsored by JW Pharmaceutical 08:30~08:50 / Saturday 19 September
Channel C
Chairman:Yu-Bae Ahn
Hyuk Sang Kwon
The Catholic University of Korea, Korea
 SS7 All statins are the same in safety and outcome for Asian?
Satellite symposium 8 Sponsored by Lilly 08:30~08:50 / Saturday 19 September
Channel D
Chairman:Yong-Wook Cho
Sin Gon Kim
Korea University, Korea
 SS8 From CVOTs to practice: focused on GLP-1 receptor agonists
Satellite symposium 9 Sponsored by Dong-A ST 12:30-12:50 / Saturday 19 September
Channel A
Chairman:Chul-Hee Kim
Gyuri Kim
Sungkyunkwan University, Korea
 SS9 Advanced clinical outcomes on 24hr glucose control-based on EVERGREEN study
Satellite symposium 10 Sponsored by Astrazeneca 12:30-12:50 / Saturday 19 September
Channel B
Chairman:Chang Beom Lee
Eunjung Rhee
Sungkyunkwan University, Korea
 SS10 See the unseen: SGLT2 inhibitor's glucose control with renal benefit in T2DM
Satellite symposium 11 Sponsored by Daewoong 12:30-12:50 / Saturday 19 September
Channel C
Chairman:Kyung Ah Han
Jong Chul Won
Inje University, Korea
 SS11 Get the time in range: review of clinical evidence on the use of CGMs
  • Korean Diabetes Association
    101-2104, Lotte Castle President, 109
    Mapo-gu, Seoul, 04146, Korea

    E-mail : icdm@diabetes.or.kr

  • Congress Secretariat (The Within)
    5F, Samgyeong Bldg., #100-20, Yanghwa-ro, Mapo-gu, Seoul, Korea

    TEL : 82-070-5014-1347 FAX : . 82-70-8677-6333 E-mail : icdm@diabetes.or.kr